Unsubscribe from all Eupraxia Pharmaceuticals Inc. email alerts

Resources

Investor FAQs
Information Request Form
Investor Email Alerts
Investor Contacts

Unsubscribe from all Eupraxia Pharmaceuticals Inc. email alerts

Email Address

Leave this field blank

Investor Contact

Kevin Gardner
Investor relations on behalf of Eupraxia Pharmaceuticals

draftskgardner@lifesciadvisors.com
draftsinvestors@eupraxiapharma.com

phone_iphone +617-283-2856

Subscribe to our Email Alerts

Email Address Required

Eupraxia is a clinical-stage biotechnology company developing targeted therapies that leverage a proprietary extended-release delivery system to provide the right dose of a drug in the right place for the right amount of time.

Vancouver lab & office:
Eupraxia Pharmaceuticals
2198 Yukon St,
Vancouver, BC, V5Y 3P1
Canada

Get in Touch

Contact
Careers
250-590-3968

Follow us on :

Privacy Policy
Term of Use
IR Email Alerts

Search Investors

Search this site